About Me

header ads

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.

from News Medical Medical Research News Feed https://ift.tt/2J6uvVb

Post a Comment

0 Comments